{
    "applicationNumber": "BR 11 2022 014722-8",
    "filingDate": "12/02/2021",
    "grantDate": null,
    "title": "RECEPTORES DE ANT\u00cdGENO QUIM\u00c9RICOS COM ATIVA\u00c7\u00c3O DE CD2",
    "nationalPhaseDate": [
        "26/07/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2021/018027",
        "pctDate": "12/02/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/976,997",
            "priorityDate": "14/02/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/109,831",
            "priorityDate": "04/11/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2691"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2701"
        }
    ],
    "inventors": [
        "ROBBIE G MAJZNER",
        "CRYSTAL L MACKALL",
        "AIDAN TOUSLEY",
        "MICHELLE MONJE",
        "LOUAI LABANIEH",
        "CHRISTOPHER MOUNT"
    ],
    "holders": [
        87209
    ],
    "ipcCodes": [
        "C12N 15/11"
    ]
}